Dr. Rayan Hani El Sibai, MD

Dr. El Sibai practices at UPMC Western Maryland in Cumberland, Maryland, part of University of Pittsburgh Medical Center.

Dr. El Sibai's NPI, 1568921690, was assigned on March 18, 2019. Dr. El Sibai holds Maryland license D0094127.

Dr. El Sibai's primary practice is UPMC Western Maryland, at 12500 Willowbrook Road, Cumberland, MD 21502 in Allegany County. The practice phone is (240) 964-7000.

Dr. El Sibai's primary practice is UPMC Western Maryland in Cumberland, Maryland, part of University of Pittsburgh Medical Center. The medical group on file is US Acute Care Solutions (USACS). Dmand AI also links Dr. El Sibai to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. El Sibai practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. El Sibai's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. El Sibai is licensed in Maryland.

CMS data shows 1,178 Medicare services from Dr. El Sibai across 7 procedure codes in 2024, for 692 Medicare patients. Medicare paid $118,459 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 692 Medicare patients who saw Dr. El Sibai in 2024. The largest group is 75 to 84, with 253 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. El Sibai's median patient age at 58, with 51% women.

In 2024, Dr. El Sibai wrote 207 Medicare Part D claims for 142 patients. 95% of them were for generic drugs. CMS names the drug for 94 of them, across 6 drugs with 11 or more claims each, at $365 in total drug cost. In 2023, CMS named 42 claims across 3 drugs.

CMS Open Payments shows 2 general payments to Dr. El Sibai from 1 drug or device company from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $31.